News
A Vaccine Against Eye Cancer
Wednesday, February 18 2015 | 00 h 00 min | Vision Science
Researchers are currently testing a vaccine that improves the chances of recovery of patients with ocular tumors by stimulating their immune response.
Read MoreLaser 1, AMD 0
Friday, February 13 2015 | 00 h 00 min | Vision Science
A new laser treatment administered during early stages of age-related macular degeneration may slow, even reverse, the progression of the disease.
Read MoreSunglasses at your fingertips
Thursday, February 12 2015 | 00 h 00 min | Vision Science
Researchers at the Georgia Institute of Technology in the United States have created a corrective lens that tints on demand.
Read More
Vision-Ease announces an appointment and an invitation
Tuesday, February 10 2015 | 00 h 00 min | News
Grady Lenski is the new vice president of sales, North America, for Vision-Ease.
Read MoreIsabelle Boin-Serveau Appointed as Editor for Opt!K Magazine
Monday, February 9 2015 | 00 h 00 min | News
David Pietrobon, President of Vuepoint IDS and publisher of the bilingual magazine Opt!k, has announced the appointment of Isabelle Boin-Serveau to the editorial team led by Charleen Wyman, Managing Editor.
Read More
New Project Manager Announced for the Opti International Trade Show
Friday, February 6 2015 | 00 h 00 min | News
Bettina Reiter will be taking on the role of project manager at Opi, the International Trade Show for Optics and Design in Germany.
Read More
FYidoctors Creates New Flagship Facility in SW Ontario
Thursday, February 5 2015 | 00 h 00 min | News
FYidoctors have consolidated five local traditional practices in Sarnia, Ontario into a new fully equipped 5,400 square foot facility.
Read More
New General Manager for De Rigo Vision USA
Thursday, February 5 2015 | 00 h 00 min | News
Iraj Kamili has been appointed CEO of De Rigo Vision, USA.
Read More
HOYA Corp Sales Up on Good Ophthalmic Lens Results
Thursday, February 5 2015 | 00 h 00 min | News
HOYA announced sales up 16.9% and profit before tax up 22.9% for the third fiscal quarter 2014 (October –December) compared to the same period last year.
Read MoreNovartis and its Alcon Division Report Marginally Increased Global Sales in 2014
Wednesday, February 4 2015 | 00 h 00 min | News
Novartis sales increased 1%, or 3% at constant exchange rates to $ US 58 billion ($74 billion CDN).
Read More
